Afshan Nanji1, Travis Redd1,2, Winston Chamberlain1, Julie M Schallhorn2, Siyu Chen3, Stefan Ploner3,4, Andreas Maier4, James G Fujimoto3, Yali Jia1, David Huang1, Yan Li1. 1. Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR. 2. Department of Ophthalmology, University of California San Francisco, San Francisco, CA. 3. Department of Electrical Engineering & Computer Science and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA; and. 4. Pattern Recognition Lab and SAOT, University Erlangen Nuremberg, Erlangen, Germany.
Abstract
PURPOSE: To map and measure the depths of corneal neovascularization (NV) using 3-dimensional optical coherence tomography angiography (OCTA) at 2 different wavelengths. METHODS: Corneal NV of varying severity, distribution, and underlying etiology was examined. Average NV depth and vessel density were measured using 840-nm spectral-domain OCTA and 1050-nm swept-source OCTA. The OCTA results were compared with clinical slit-lamp estimation of NV depth. RESULTS: Twelve eyes with corneal NV from 12 patients were imaged with OCTA. Clinically "superficial," "midstromal," and "deep" cases had an average vessel depth of 23%, 39%, and 66% on 1050-nm OCTA, respectively. Average vessel depth on OCTA followed a statistically significant ordinal trend according to the clinical classification of vessel depth (Jonckheere-Terpstra test, P < 0.001). In 8 cases where both 840-nm OCTA and 1050-nm OCTA were acquired, there was excellent agreement in the mean vessel depth between the 2 systems (concordance correlation coefficient = 0.94, P < 0.001). The average vessel density measured by 840-nm OCTA was higher (average 1.6-fold) than that measured by 1050-nm OCTA. CONCLUSIONS: Corneal OCTA was able to map corneal NV in 3 dimensions and measure vessel depth and density. The depth of corneal NV varied between different pathologies in a manner consistent with previous pathologic studies. The measured vessel density appeared to be affected by the interscan time, which affects blood flow velocity sensitivity, and the wavelength, which affects the ability to penetrate through opacity. These findings suggest possible clinical applications of OCTA for the diagnosis of corneal pathology and quantitative monitoring of therapeutic response in patients with corneal NV.
PURPOSE: To map and measure the depths of corneal neovascularization (NV) using 3-dimensional optical coherence tomography angiography (OCTA) at 2 different wavelengths. METHODS: Corneal NV of varying severity, distribution, and underlying etiology was examined. Average NV depth and vessel density were measured using 840-nm spectral-domain OCTA and 1050-nm swept-source OCTA. The OCTA results were compared with clinical slit-lamp estimation of NV depth. RESULTS: Twelve eyes with corneal NV from 12 patients were imaged with OCTA. Clinically "superficial," "midstromal," and "deep" cases had an average vessel depth of 23%, 39%, and 66% on 1050-nm OCTA, respectively. Average vessel depth on OCTA followed a statistically significant ordinal trend according to the clinical classification of vessel depth (Jonckheere-Terpstra test, P < 0.001). In 8 cases where both 840-nm OCTA and 1050-nm OCTA were acquired, there was excellent agreement in the mean vessel depth between the 2 systems (concordance correlation coefficient = 0.94, P < 0.001). The average vessel density measured by 840-nm OCTA was higher (average 1.6-fold) than that measured by 1050-nm OCTA. CONCLUSIONS: Corneal OCTA was able to map corneal NV in 3 dimensions and measure vessel depth and density. The depth of corneal NV varied between different pathologies in a manner consistent with previous pathologic studies. The measured vessel density appeared to be affected by the interscan time, which affects blood flow velocity sensitivity, and the wavelength, which affects the ability to penetrate through opacity. These findings suggest possible clinical applications of OCTA for the diagnosis of corneal pathology and quantitative monitoring of therapeutic response in patients with corneal NV.
Authors: WooJhon Choi; Eric M Moult; Nadia K Waheed; Mehreen Adhi; ByungKun Lee; Chen D Lu; Talisa E de Carlo; Vijaysekhar Jayaraman; Philip J Rosenfeld; Jay S Duker; James G Fujimoto Journal: Ophthalmology Date: 2015-10-17 Impact factor: 12.079
Authors: Marcus Ang; Mani Baskaran; René M Werkmeister; Jacqueline Chua; Doreen Schmidl; Valentin Aranha Dos Santos; Gerhard Garhöfer; Jodhbir S Mehta; Leopold Schmetterer Journal: Prog Retin Eye Res Date: 2018-04-07 Impact factor: 21.198
Authors: Claus Cursiefen; Joseph Colin; Reza Dana; Manuel Diaz-Llopis; Lana A Faraj; Salvador Garcia-Delpech; Gerd Geerling; Francis W Price; Lies Remeijer; Barry T Rouse; Berthold Seitz; Patricia Udaondo; Daniel Meller; Harminder Dua Journal: Br J Ophthalmol Date: 2011-06-28 Impact factor: 4.638
Authors: Eric Moult; WooJhon Choi; Nadia K Waheed; Mehreen Adhi; ByungKun Lee; Chen D Lu; Vijaysekhar Jayaraman; Benjamin Potsaid; Philip J Rosenfeld; Jay S Duker; James G Fujimoto Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2014 Nov-Dec Impact factor: 1.300
Authors: Ruaidhrí P Kirwan; Yalin Zheng; Adrian Tey; Deepa Anijeet; Henri Sueke; Stephen B Kaye Journal: Am J Ophthalmol Date: 2012-07-26 Impact factor: 5.258
Authors: Martin F Kraus; Jonathan J Liu; Julia Schottenhamml; Chieh-Li Chen; Attila Budai; Lauren Branchini; Tony Ko; Hiroshi Ishikawa; Gadi Wollstein; Joel Schuman; Jay S Duker; James G Fujimoto; Joachim Hornegger Journal: Biomed Opt Express Date: 2014-07-11 Impact factor: 3.732
Authors: Jonathan Luisi; Edward R Kraft; Steven A Giannos; Krishna Patel; Mary E Schmitz-Brown; Valentina Reffatto; Kevin H Merkley; Praveena K Gupta Journal: Transl Vis Sci Technol Date: 2021-03-01 Impact factor: 3.283